Effect of Sobatum on radiation-induced toxicity in mice

Sobatum, the active fraction of the plant Solanum trilobatum was obtained from the petroleum ether/ethyl acetate (75:25) extractable portion. Sobatum was proven to be an anticancer agent by in vitro and in vivo methods. The aim of this study is to evaluate the effect of Sobatum on radiation-induced...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 1998-01, Vol.123 (2), p.141-145
Hauptverfasser: Mohanan, P.V, Devi, K.S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 145
container_issue 2
container_start_page 141
container_title Cancer letters
container_volume 123
creator Mohanan, P.V
Devi, K.S
description Sobatum, the active fraction of the plant Solanum trilobatum was obtained from the petroleum ether/ethyl acetate (75:25) extractable portion. Sobatum was proven to be an anticancer agent by in vitro and in vivo methods. The aim of this study is to evaluate the effect of Sobatum on radiation-induced toxicity in mice. In this assay there are three groups. Group I, the control group, received radiation alone, while groups II and III received Sobatum (100 and 200 mg/kg body weight, respectively) with radiation. Sobatum was administered 24 h before radiation and was continued for 4 alternate days. Body weight, food intake and blood parameters were determined before radiation and every 3 days after radiation for 17 days. The results indicated that there was significantly less body weight gain and food intake in the radiation alone-treated group compared to the Sobatum-treated group. The average leukocyte count and haemoglobin level of the Sobatum-treated group was considerably improved at the end of the experimental period. Hence, it can be concluded that Sobatum reduced the side-effects of radiation-induced toxicity and suggested that it could be used along with radiation therapy.
doi_str_mv 10.1016/S0304-3835(97)00408-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16360274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383597004084</els_id><sourcerecordid>16360274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-683230f1c99e4976a60539e13f8f6c58b8ceab885c1adfa9fa8d7034524deb583</originalsourceid><addsrcrecordid>eNqFkEtLAzEQgIMotVZ_QmEPInpYnWySTXISKfUBBQ_Vc8hmE4h0NzXZFfvv3T7oVRiYw3zz-hCaYrjHgMuHJRCgORGE3Up-B0BB5PQEjbHgRc6lgFM0PiLn6CKlLwBglLMRGkkqhoAx4nPnrOmy4LJlqHTXN1los6hrrzsf2ty3dW9snXXh1xvfbTLfZo039hKdOb1K9uqQJ-jzef4xe80X7y9vs6dFbhhmXV4KUhBw2EhpqeSlLoERaTFxwpWGiUoYqyshmMG6dlo6LWoOhLKC1rZigkzQzX7uOobv3qZONT4Zu1rp1oY-KVySEgpOB5DtQRNDStE6tY6-0XGjMKitMLUTprY2lORqJ0xt-6aHBX3V2PrYdTA01K8PdZ2MXrmoW-PTESsKToa_Buxxj9lBxo-3USXjbTuo83Hwq-rg_znkD08ohhM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16360274</pqid></control><display><type>article</type><title>Effect of Sobatum on radiation-induced toxicity in mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mohanan, P.V ; Devi, K.S</creator><creatorcontrib>Mohanan, P.V ; Devi, K.S</creatorcontrib><description>Sobatum, the active fraction of the plant Solanum trilobatum was obtained from the petroleum ether/ethyl acetate (75:25) extractable portion. Sobatum was proven to be an anticancer agent by in vitro and in vivo methods. The aim of this study is to evaluate the effect of Sobatum on radiation-induced toxicity in mice. In this assay there are three groups. Group I, the control group, received radiation alone, while groups II and III received Sobatum (100 and 200 mg/kg body weight, respectively) with radiation. Sobatum was administered 24 h before radiation and was continued for 4 alternate days. Body weight, food intake and blood parameters were determined before radiation and every 3 days after radiation for 17 days. The results indicated that there was significantly less body weight gain and food intake in the radiation alone-treated group compared to the Sobatum-treated group. The average leukocyte count and haemoglobin level of the Sobatum-treated group was considerably improved at the end of the experimental period. Hence, it can be concluded that Sobatum reduced the side-effects of radiation-induced toxicity and suggested that it could be used along with radiation therapy.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(97)00408-4</identifier><identifier>PMID: 9489480</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Animals ; Anticarcinogenic Agents - pharmacology ; Antineoplastic agents ; Biological and medical sciences ; Body Weight - drug effects ; Body Weight - radiation effects ; Combined treatments (chemotherapy of immunotherapy associated with an other treatment) ; Cytotoxicity ; DLA ; Eating - drug effects ; Eating - radiation effects ; Evaluation Studies as Topic ; Haemoglobin ; Hemoglobins - drug effects ; Hemoglobins - radiation effects ; Leukocyte Count - drug effects ; Leukocyte Count - radiation effects ; Leukocytes ; Male ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; Plant Extracts - pharmacology ; Radiation ; Radiation Injuries, Experimental - mortality ; Radiation Injuries, Experimental - prevention &amp; control ; Sobatum ; Survival Rate</subject><ispartof>Cancer letters, 1998-01, Vol.123 (2), p.141-145</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515t-683230f1c99e4976a60539e13f8f6c58b8ceab885c1adfa9fa8d7034524deb583</citedby><cites>FETCH-LOGICAL-c515t-683230f1c99e4976a60539e13f8f6c58b8ceab885c1adfa9fa8d7034524deb583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383597004084$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2273976$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9489480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohanan, P.V</creatorcontrib><creatorcontrib>Devi, K.S</creatorcontrib><title>Effect of Sobatum on radiation-induced toxicity in mice</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Sobatum, the active fraction of the plant Solanum trilobatum was obtained from the petroleum ether/ethyl acetate (75:25) extractable portion. Sobatum was proven to be an anticancer agent by in vitro and in vivo methods. The aim of this study is to evaluate the effect of Sobatum on radiation-induced toxicity in mice. In this assay there are three groups. Group I, the control group, received radiation alone, while groups II and III received Sobatum (100 and 200 mg/kg body weight, respectively) with radiation. Sobatum was administered 24 h before radiation and was continued for 4 alternate days. Body weight, food intake and blood parameters were determined before radiation and every 3 days after radiation for 17 days. The results indicated that there was significantly less body weight gain and food intake in the radiation alone-treated group compared to the Sobatum-treated group. The average leukocyte count and haemoglobin level of the Sobatum-treated group was considerably improved at the end of the experimental period. Hence, it can be concluded that Sobatum reduced the side-effects of radiation-induced toxicity and suggested that it could be used along with radiation therapy.</description><subject>Animals</subject><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Body Weight - radiation effects</subject><subject>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</subject><subject>Cytotoxicity</subject><subject>DLA</subject><subject>Eating - drug effects</subject><subject>Eating - radiation effects</subject><subject>Evaluation Studies as Topic</subject><subject>Haemoglobin</subject><subject>Hemoglobins - drug effects</subject><subject>Hemoglobins - radiation effects</subject><subject>Leukocyte Count - drug effects</subject><subject>Leukocyte Count - radiation effects</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - pharmacology</subject><subject>Radiation</subject><subject>Radiation Injuries, Experimental - mortality</subject><subject>Radiation Injuries, Experimental - prevention &amp; control</subject><subject>Sobatum</subject><subject>Survival Rate</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLAzEQgIMotVZ_QmEPInpYnWySTXISKfUBBQ_Vc8hmE4h0NzXZFfvv3T7oVRiYw3zz-hCaYrjHgMuHJRCgORGE3Up-B0BB5PQEjbHgRc6lgFM0PiLn6CKlLwBglLMRGkkqhoAx4nPnrOmy4LJlqHTXN1los6hrrzsf2ty3dW9snXXh1xvfbTLfZo039hKdOb1K9uqQJ-jzef4xe80X7y9vs6dFbhhmXV4KUhBw2EhpqeSlLoERaTFxwpWGiUoYqyshmMG6dlo6LWoOhLKC1rZigkzQzX7uOobv3qZONT4Zu1rp1oY-KVySEgpOB5DtQRNDStE6tY6-0XGjMKitMLUTprY2lORqJ0xt-6aHBX3V2PrYdTA01K8PdZ2MXrmoW-PTESsKToa_Buxxj9lBxo-3USXjbTuo83Hwq-rg_znkD08ohhM</recordid><startdate>19980101</startdate><enddate>19980101</enddate><creator>Mohanan, P.V</creator><creator>Devi, K.S</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>19980101</creationdate><title>Effect of Sobatum on radiation-induced toxicity in mice</title><author>Mohanan, P.V ; Devi, K.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-683230f1c99e4976a60539e13f8f6c58b8ceab885c1adfa9fa8d7034524deb583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Body Weight - radiation effects</topic><topic>Combined treatments (chemotherapy of immunotherapy associated with an other treatment)</topic><topic>Cytotoxicity</topic><topic>DLA</topic><topic>Eating - drug effects</topic><topic>Eating - radiation effects</topic><topic>Evaluation Studies as Topic</topic><topic>Haemoglobin</topic><topic>Hemoglobins - drug effects</topic><topic>Hemoglobins - radiation effects</topic><topic>Leukocyte Count - drug effects</topic><topic>Leukocyte Count - radiation effects</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - pharmacology</topic><topic>Radiation</topic><topic>Radiation Injuries, Experimental - mortality</topic><topic>Radiation Injuries, Experimental - prevention &amp; control</topic><topic>Sobatum</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohanan, P.V</creatorcontrib><creatorcontrib>Devi, K.S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohanan, P.V</au><au>Devi, K.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Sobatum on radiation-induced toxicity in mice</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1998-01-01</date><risdate>1998</risdate><volume>123</volume><issue>2</issue><spage>141</spage><epage>145</epage><pages>141-145</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>Sobatum, the active fraction of the plant Solanum trilobatum was obtained from the petroleum ether/ethyl acetate (75:25) extractable portion. Sobatum was proven to be an anticancer agent by in vitro and in vivo methods. The aim of this study is to evaluate the effect of Sobatum on radiation-induced toxicity in mice. In this assay there are three groups. Group I, the control group, received radiation alone, while groups II and III received Sobatum (100 and 200 mg/kg body weight, respectively) with radiation. Sobatum was administered 24 h before radiation and was continued for 4 alternate days. Body weight, food intake and blood parameters were determined before radiation and every 3 days after radiation for 17 days. The results indicated that there was significantly less body weight gain and food intake in the radiation alone-treated group compared to the Sobatum-treated group. The average leukocyte count and haemoglobin level of the Sobatum-treated group was considerably improved at the end of the experimental period. Hence, it can be concluded that Sobatum reduced the side-effects of radiation-induced toxicity and suggested that it could be used along with radiation therapy.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9489480</pmid><doi>10.1016/S0304-3835(97)00408-4</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1998-01, Vol.123 (2), p.141-145
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_16360274
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Anticarcinogenic Agents - pharmacology
Antineoplastic agents
Biological and medical sciences
Body Weight - drug effects
Body Weight - radiation effects
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Cytotoxicity
DLA
Eating - drug effects
Eating - radiation effects
Evaluation Studies as Topic
Haemoglobin
Hemoglobins - drug effects
Hemoglobins - radiation effects
Leukocyte Count - drug effects
Leukocyte Count - radiation effects
Leukocytes
Male
Medical sciences
Mice
Pharmacology. Drug treatments
Plant Extracts - pharmacology
Radiation
Radiation Injuries, Experimental - mortality
Radiation Injuries, Experimental - prevention & control
Sobatum
Survival Rate
title Effect of Sobatum on radiation-induced toxicity in mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T09%3A38%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Sobatum%20on%20radiation-induced%20toxicity%20in%20mice&rft.jtitle=Cancer%20letters&rft.au=Mohanan,%20P.V&rft.date=1998-01-01&rft.volume=123&rft.issue=2&rft.spage=141&rft.epage=145&rft.pages=141-145&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(97)00408-4&rft_dat=%3Cproquest_cross%3E16360274%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16360274&rft_id=info:pmid/9489480&rft_els_id=S0304383597004084&rfr_iscdi=true